TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 6891608

Group type: EXPERIMENTAL
Intervention: 5 alpha‐androst‐16‐en‐3 alpha‐ol (androstenol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 29283670

Group type: EXPERIMENTAL
Intervention: Telephone-delivered home-based health coaching intervention over 20 weeks
Number of subjects: 325

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 325

Group type: EXPERIMENTAL
Intervention: Home-based health coaching intervention
Number of subjects: 325
Study: 27130812

Group type: EXPERIMENTAL
Intervention: Caregivers who perceived it easy to remember medication names
Number of subjects: 141

Group type: COMPARATOR
Intervention: Caregivers who did not easily remember medication names
Number of subjects: 141
Study: 25563879

Group type: EXPERIMENTAL
Intervention: Dexamethasone (8 mg)
Number of subjects: 152

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 152
Study: 24908910

Group type: EXPERIMENTAL
Intervention: Pedometer Group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: DVD Group
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Pedometer + DVD Group
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 24
Study: 20562295

Group type: EXPERIMENTAL
Intervention: 4 mM theophylline
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: 10 mM L-NAME
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Combined 4 mM theophylline + 10 mM L-NAME
Number of subjects: 6

Group type: COMPARATOR
Intervention: Lactated Ringer solution (control)
Number of subjects: 6
Study: 18589032

Group type: EXPERIMENTAL
Intervention: Diet-only group (caloric intake reduced by 2,800 kcal/week)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise group (caloric intake reduced by 2,400 kcal/week and expended approximately 400 kcal/week through aerobic exercise)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Higher dietary protein intake (0.62 g/kg body weight/day)
Number of subjects: 0
Study: 16025960

Group type: COMPARATOR
Intervention: Drug-therapy plus acupuncture (Group B)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Drug-therapy plus ETSM and acupuncture (Group C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Drug-therapy only (Group A)
Number of subjects: 0
Study: 12849771

Group type: EXPERIMENTAL
Intervention: Double cue inhibition of return (IOR) procedure
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: IOR procedure combined with a Stroop task
Number of subjects: 4

Group type: COMPARATOR
Intervention: Control participants
Number of subjects: 4
Study: 10099859

Group type: EXPERIMENTAL
Intervention: Ambulatory withdrawal therapy
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Stationary withdrawal therapy
Number of subjects: 101

Group type: COMPARATOR
Intervention: Total relapse rate
Number of subjects: 101
Study: 8911442

Group type: EXPERIMENTAL
Intervention: 4 annual doses of ivermectin
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: 10 6‐monthly doses of ivermectin
Number of subjects: 77

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 77
Study: 1648597

Group type: EXPERIMENTAL
Intervention: vindesine and cisplatin (VP)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: mitomycin, vindesine, and cisplatin (MVP)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: etoposide and cisplatin alternating with vindesine and mitomycin (EP/VM)
Number of subjects: 199
Study: 6137895

Group type: EXPERIMENTAL
Intervention: Opiate analgesics (omnopon, pethidine, pentazocine)
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Naloxone (opiate/opioid antagonist)
Number of subjects: 37
Study: 31576424

Group type: EXPERIMENTAL
Intervention: GRASP + tRNS
Number of subjects: 18

Group type: COMPARATOR
Intervention: GRASP + Sham stimulation
Number of subjects: 18
Study: 29954648

Group type: EXPERIMENTAL
Intervention: Healthy eating and physical-activity-focused behavioral intervention
Number of subjects: 10
Study: 24250305

Group type: EXPERIMENTAL
Intervention: Aerobic exercise training in addition to diet regimen
Number of subjects: 100

Group type: COMPARATOR
Intervention: No treatment intervention
Number of subjects: 100
Study: 20740477

Group type: EXPERIMENTAL
Intervention: HandTutor™ combined with traditional therapy
Number of subjects: 31

Group type: COMPARATOR
Intervention: Traditional therapy
Number of subjects: 31
Study: 19965759

Group type: EXPERIMENTAL
Intervention: Relevance intervention (encouraged students to connect course materials to their lives)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 16835602

Group type: EXPERIMENTAL
Intervention: Diet C (increased consumption of cereals)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Diet V (increased consumption of vegetables)
Number of subjects: 67
Study: 15136304

Group type: EXPERIMENTAL
Intervention: Enoxaparin sodium (low-molecular-weight heparin)
Number of subjects: 1102

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 1102
Study: 11517856

Group type: EXPERIMENTAL
Intervention: Cetirizine (10 mg/three times a day for 15 days)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 9691893

Group type: EXPERIMENTAL
Intervention: Endoscopic ultrasonography (EUS)
Number of subjects: 96
Study: 7560252

Group type: EXPERIMENTAL
Intervention: Iloperidone 3 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iloperidone 5 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Iloperidone with food
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (fasted subjects)
Number of subjects: 0
Study: 2225261

Group type: EXPERIMENTAL
Intervention: Topically applied Norfloxacin 0.3%, 5 drops between 7.55 A.M. to 8 A.M. and after each hour until surgery.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topically applied Norfloxacin 0.3%, 1 drop each quarter from 7 A.M. until surgery.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Comparison between the two groups (5 drops vs 1 drop each quarter).
Number of subjects: 0
Study: 837172

Group type: EXPERIMENTAL
Intervention: 100 g or 200 g of liquorice daily for one to four weeks
Number of subjects: 14
Study: 30777001

Group type: EXPERIMENTAL
Intervention: 200 mg modafinil taken daily for 6 weeks
Number of subjects: 26
Study: 25497383

Group type: EXPERIMENTAL
Intervention: Phone follow-up with a semiquantitative urine pregnancy test and symptom checklist
Number of subjects: 2400

Group type: COMPARATOR
Intervention: In-clinic follow-up
Number of subjects: 2400
Study: 23444345

Group type: EXPERIMENTAL
Intervention: Craniospinal radiotherapy (23.4 Gy) plus adjuvant chemotherapy
Number of subjects: 110
Study: 22064991

Group type: EXPERIMENTAL
Intervention: Nicotine 2 mg
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nicotine 4 mg
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Nicotine (2 mg and 4 mg)
Number of subjects: 10
Study: 19059750

Group type: EXPERIMENTAL
Intervention: Progressive elastic stockings (ES)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Conventional elastic stockings (ES)
Number of subjects: 130
Study: 17033444

Group type: EXPERIMENTAL
Intervention: EASIE simulator training (group B)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Clinical education only (group A)
Number of subjects: 35
Study: 12775404

Group type: EXPERIMENTAL
Intervention: Modified Mini Mental State Exam (3MS)
Number of subjects: 7480
Study: 10668837

Group type: EXPERIMENTAL
Intervention: ACE inhibitors
Number of subjects: 3706

Group type: EXPERIMENTAL
Intervention: Calcium channel blockers (CCBs)
Number of subjects: 3706

Group type: EXPERIMENTAL
Intervention: Beta-blockers
Number of subjects: 3706

Group type: EXPERIMENTAL
Intervention: Short-acting nifedipine
Number of subjects: 3706

Group type: EXPERIMENTAL
Intervention: Sustained-release nifedipine
Number of subjects: 3706

Group type: COMPARATOR
Intervention: Nonusers of antihypertensive drugs
Number of subjects: 3706
Study: 7490809

Group type: EXPERIMENTAL
Intervention: Electrical stimulation for stress urinary incontinence
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Electrical stimulation for detrusor instability
Number of subjects: 57

Group type: COMPARATOR
Intervention: Kegel exercise for stress urinary incontinence
Number of subjects: 57

Group type: COMPARATOR
Intervention: Anticholinergic therapy for detrusor instability
Number of subjects: 57
Study: 1593852

Group type: EXPERIMENTAL
Intervention: Triple treatment (low-dose cyclosporine, azathioprine, methylprednisolone)
Number of subjects: 128

Group type: COMPARATOR
Intervention: Combinations of two immunosuppressive drugs
Number of subjects: 128
Study: 6739393

Group type: EXPERIMENTAL
Intervention: General support garments (roller bandage with shaped tubigrip - SBB - Seton and Sigvaris stockings)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Anti-embolism supports (roller bandage plus pressure garment - Seton)
Number of subjects: 98
Study: 30795785

Group type: EXPERIMENTAL
Intervention: 30 mg/day crocin (2 plus crocin tablet, 15 mg BID)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo (2 tablets per day, 15 mg BID)
Number of subjects: 50
Study: 29228255

Group type: EXPERIMENTAL
Intervention: 5-year community-wide intervention (CWI) using social marketing to promote physical activity (PA)
Number of subjects: 4414

Group type: EXPERIMENTAL
Intervention: 5-year community-wide intervention (CWI)
Number of subjects: 4414

Group type: COMPARATOR
Intervention: Bundled approach promoting all forms of PA simultaneously
Number of subjects: 4414

Group type: EXPERIMENTAL
Intervention: CWI awareness
Number of subjects: 4414

Group type: COMPARATOR
Intervention: Intervention and control groups
Number of subjects: 4414
Study: 26497264

Group type: EXPERIMENTAL
Intervention: Medicaid coverage
Number of subjects: 10643

Group type: COMPARATOR
Intervention: Not assigned to apply for Medicaid (Control)
Number of subjects: 10643
Study: 24356073

Group type: EXPERIMENTAL
Intervention: Specialist nurse-led hypertension clinic (n = 144)
Number of subjects: 353

Group type: COMPARATOR
Intervention: Usual care (n = 169)
Number of subjects: 353
Study: 22207268

Group type: EXPERIMENTAL
Intervention: Perflubutane-based ultrasound
Number of subjects: 202

Group type: COMPARATOR
Intervention: FIB4
Number of subjects: 202
Study: 19856040

Group type: EXPERIMENTAL
Intervention: 30 mg isobaric mepivacaine 1.5% plus 10 microg fentanyl (M + F group)
Number of subjects: 34

Group type: COMPARATOR
Intervention: 45 mg isobaric mepivacaine 1.5% (M group)
Number of subjects: 34
Study: 17643363

Group type: EXPERIMENTAL
Intervention: Low dialysate calcium (LCD) 1.25 mmol/l
Number of subjects: 52

Group type: COMPARATOR
Intervention: High calcium dialysate (HCD) 1.75 mmol/l
Number of subjects: 52
Study: 16008972

Group type: EXPERIMENTAL
Intervention: Classical UPPP (cUPPP)
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Modified UPPP (mUPPP)
Number of subjects: 68

Group type: COMPARATOR
Intervention: CPAP treatment
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: BiPAP therapy
Number of subjects: 68
Study: 12221159

Group type: EXPERIMENTAL
Intervention: Amantadine (usually 400 mg/d)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 9791817

Group type: EXPERIMENTAL
Intervention: Single ablation zone of 5.5 mm
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ablation zone of 5.5 mm with a transition zone of 1.0 mm
Number of subjects: 60
Study: 8554732

Group type: EXPERIMENTAL
Intervention: Acute losartan therapy (50 mg single dose)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Chronic losartan therapy (42 days)
Number of subjects: 11
Study: 2088623

Group type: EXPERIMENTAL
Intervention: Vinyl glove
Number of subjects: 29

Group type: COMPARATOR
Intervention: Latex glove
Number of subjects: 29
Study: 122333

Group type: EXPERIMENTAL
Intervention: Cimetidine 1g daily for 4 weeks
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo tablets of identical appearance for 4 weeks
Number of subjects: 27
Study: 31951932

Group type: EXPERIMENTAL
Intervention: Refined barley flour bread
Number of subjects: 23

Group type: COMPARATOR
Intervention: Refined wheat flour bread
Number of subjects: 23
Study: 31127837

Group type: EXPERIMENTAL
Intervention: Group acupuncture (once weekly for 12 weeks)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Group acupuncture (twice weekly for 12 weeks)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Group acupuncture (once or twice weekly for 12 weeks)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 40
Study: 28103704

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 61

Group type: COMPARATOR
Intervention: Health education control (HEC)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Smoking cessation counseling and nicotine patches
Number of subjects: 61
Study: 25482435

Group type: EXPERIMENTAL
Intervention: Home administration of 200mg mifepristone
Number of subjects: 200

Group type: COMPARATOR
Intervention: Clinic administration of 200mg mifepristone
Number of subjects: 200
Study: 23370794

Group type: EXPERIMENTAL
Intervention: Ketamine infusion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lamotrigine pretreatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risperidone pretreatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 20638864

Group type: EXPERIMENTAL
Intervention: Biventricular pacing (BiVP) optimization
Number of subjects: 22
Study: 18951599

Group type: EXPERIMENTAL
Intervention: Circulating cathodic antigen (CCA) urine reagent strip
Number of subjects: 265

Group type: EXPERIMENTAL
Intervention: Praziquantel treatment
Number of subjects: 265

Group type: COMPARATOR
Intervention: Egg detection
Number of subjects: 265
Study: 17298705

Group type: EXPERIMENTAL
Intervention: Prebiotic bread
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Pre-aox-bread
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control bread (placebo)
Number of subjects: 38
Study: 15249280

Group type: EXPERIMENTAL
Intervention: Rivastigmine
Number of subjects: 2010
Study: 11315833

Group type: EXPERIMENTAL
Intervention: Chronic care clinics (intervention)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 8
Study: 9352174

Group type: EXPERIMENTAL
Intervention: Intracoronary irradiation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 8203982

Group type: EXPERIMENTAL
Intervention: Low-dose GH (0.1 mg/kg)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-dose GH (0.2 mg/kg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pooled analysis of GH-treated patients
Number of subjects: 12
Study: 3316514

Group type: EXPERIMENTAL
Intervention: Cyclophosphamide monotherapy
Number of subjects: 1032

Group type: EXPERIMENTAL
Intervention: CMF (Cyclophosphamide, Methotrexate, and 5‐fluorouracil)
Number of subjects: 1032

Group type: COMPARATOR
Intervention: Observation alone
Number of subjects: 1032
Study: 31480897

Group type: EXPERIMENTAL
Intervention: COP movement tracking training in dynamic mode (unstable)
Number of subjects: 26

Group type: COMPARATOR
Intervention: COP movement tracking training in static mode (stable)
Number of subjects: 26
Study: 29172862

Group type: EXPERIMENTAL
Intervention: Spinal Anesthesia
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Ischiorectal Block
Number of subjects: 70
Study: 28219088

Group type: EXPERIMENTAL
Intervention: Single-Bundle (SB) ACL reconstruction
Number of subjects: 60

Group type: COMPARATOR
Intervention: Double-Bundle (DB) ACL reconstruction
Number of subjects: 60
Study: 26221061

Group type: EXPERIMENTAL
Intervention: Optive (compatible solutes) eye drops
Number of subjects: 24

Group type: COMPARATOR
Intervention: Hylogel (sodium hyaluronate 0.2%)
Number of subjects: 24
Study: 23024098

Group type: EXPERIMENTAL
Intervention: 25% dextrose (25 D)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Expressed breast milk (EBM)
Number of subjects: 210

Group type: COMPARATOR
Intervention: Sterile water (SW)
Number of subjects: 210
Study: 20499394

Group type: EXPERIMENTAL
Intervention: Urn randomization
Number of subjects: 30

Group type: COMPARATOR
Intervention: Simple randomization
Number of subjects: 30
Study: 18200020

Group type: EXPERIMENTAL
Intervention: sPLA(2) activity in infants with documented sepsis
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: CRP concentration in infants with documented sepsis
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: I/T ratio in infants with documented sepsis
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: sPLA(2) activity in infants with respiratory distress syndrome (RDS)
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: sPLA(2) compared to CRP
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: sPLA(2) compared to I/T ratio
Number of subjects: 156
Study: 15850126

Group type: EXPERIMENTAL
Intervention: Involved side flexor strength at 5 weeks (p = 0.029)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Involved side flexor strength at 10 weeks (p = 0.013)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Involved side flexor strength at 4 months (p = 0.021)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Flexor/extensor strength ratio in men on involved side (p = 0.119)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Strength values normalized to uninvolved knee
Number of subjects: 102
Study: 12612277

Group type: EXPERIMENTAL
Intervention: Aqueous nasal beclomethasone (400 micro g/d for 4 weeks, then 200 micro g/d for 24 weeks)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Aqueous nasal beclomethasone (200 micro g/d for 24 weeks)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Saline solution (control)
Number of subjects: 53
Study: 10561358

Group type: EXPERIMENTAL
Intervention: Topotecan and cytarabine
Number of subjects: 86
Study: 8627081

Group type: EXPERIMENTAL
Intervention: Antibody levels to pertussis toxin (PT) measured by ELISA
Number of subjects: 585

Group type: EXPERIMENTAL
Intervention: Antibody levels to filamentous hemagglutinin (FHA) measured by ELISA
Number of subjects: 585

Group type: EXPERIMENTAL
Intervention: Antibody levels to PT and FHA
Number of subjects: 585
Study: 1750720

Group type: EXPERIMENTAL
Intervention: Uniphyl tablets taken with food
Number of subjects: 22

Group type: COMPARATOR
Intervention: Uniphyl tablets taken under fasting conditions
Number of subjects: 22
Study: 7149102

Group type: EXPERIMENTAL
Intervention: Oxamniquine (20 mg/kg a day for 3 days)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Niridazole (15 mg/kg a day for 8 days)
Number of subjects: 116
Study: 30798410

Group type: EXPERIMENTAL
Intervention: High sleep quality (SQI ≥ 80)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Low sleep quality (SQI < 60)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: CPC sleep quality (SQI)
Number of subjects: 100
Study: 28673802

Group type: EXPERIMENTAL
Intervention: Regular Activity Breaks (RAB)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: RAB + Continuous Walking (RAB + PAD1)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: RAB + PAD1
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: RAB
Number of subjects: 36

Group type: COMPARATOR
Intervention: SIT (Control)
Number of subjects: 36
Study: 26012289

Group type: EXPERIMENTAL
Intervention: Intervention group (parents record daily symptom scores and receive short messages from doctors)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (parents do not record daily symptom scores and do not receive short messages)
Number of subjects: 100
Study: 23371291

Group type: EXPERIMENTAL
Intervention: Referral for genetic counseling
Number of subjects: 2524

Group type: EXPERIMENTAL
Intervention: Genetic testing
Number of subjects: 2524

Group type: EXPERIMENTAL
Intervention: Caucasian women with higher income and education levels
Number of subjects: 2524

Group type: EXPERIMENTAL
Intervention: BRCA testing
Number of subjects: 2524
Study: 21323732

Group type: EXPERIMENTAL
Intervention: Lotrafilcon A contact lenses (high Dk)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Etafilcon A contact lenses (low Dk)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Orbscan measurements with 0.92 acoustic factor
Number of subjects: 20
Study: 19955069

Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Movie
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control
Number of subjects: 38
Study: 17418836

Group type: EXPERIMENTAL
Intervention: Low dose of acarbose
Number of subjects: 0
Study: 15119636

Group type: COMPARATOR
Intervention: Dialysate volume of 2.0 L
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Dialysate volume of 2.5 L
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Dialysate volume of 3.0 L
Number of subjects: 13
Study: 11515707

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg daily (increased to 10 mg if BP > 140/90 mmHg)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Nifedipine retard 20 mg twice daily (increased to 40 mg if BP > 140/90 mmHg)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 64

Group type: COMPARATOR
Intervention: Nifedipine retard
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 64
Study: 11233385

Group type: EXPERIMENTAL
Intervention: Prazosin GITS
Number of subjects: 54

Group type: COMPARATOR
Intervention: Nifedipine SR
Number of subjects: 54
Study: 7837756

Group type: EXPERIMENTAL
Intervention: Vacuum therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned)
Number of subjects: 0
Study: 2842677

Group type: EXPERIMENTAL
Intervention: Monovalent Japanese encephalitis vaccine (n = 21,628)
Number of subjects: 65224

Group type: EXPERIMENTAL
Intervention: Bivalent Japanese encephalitis vaccine (n = 22,080)
Number of subjects: 65224

Group type: COMPARATOR
Intervention: Tetanus toxoid placebo (n = 21,516)
Number of subjects: 65224

Group type: EXPERIMENTAL
Intervention: Both vaccine groups combined
Number of subjects: 65224
Study: 31625764

Group type: EXPERIMENTAL
Intervention: Indoor nature exposure (room with natural elements)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (room without natural elements)
Number of subjects: 0
Study: 29751205

Group type: EXPERIMENTAL
Intervention: Relaxation Training (RT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Emotional Awareness and Expression Training (EAET)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waitlist Control
Number of subjects: 0
Study: 28051357

Group type: EXPERIMENTAL
Intervention: Mobile phone-assisted case management program
Number of subjects: 61